Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) Stock Has Consensus Price Target of $16.40

Shares of Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) have been given a consensus recommendation of “Buy” by the six research firms that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have given a buy rating and two have assigned a strong buy rating to the company. The average 12-month price target among analysts that have covered the stock in the last year is $16.40.

A number of research firms recently issued reports on LMRI. Barclays boosted their target price on shares of Lumexa Imaging from $9.00 to $13.00 and gave the company an “overweight” rating in a research report on Friday, August 28th. KeyCorp initiated coverage on Lumexa Imaging in a research note on Thursday, September 24th. They set an “overweight” rating and a $18.00 price objective for the company. Raymond James Financial set a $17.00 target price on shares of Lumexa Imaging in a research note on Monday, September 28th. Wall Street Zen upgraded Lumexa Imaging from a “hold” rating to a “buy” rating in a research report on Saturday, October 3rd. Finally, Truist Financial assumed coverage on shares of Lumexa Imaging in a report on Monday, October 5th. They issued a “buy” rating and a $18.00 target price on the stock.

Hedge Funds Weigh In On Lumexa Imaging

A number of hedge funds have recently modified their holdings of the business. Jupiter Topco LLC acquired a new stake in shares of Lumexa Imaging during the 2nd quarter worth about $24,269,000. Janus Henderson Group PLC raised its holdings in Lumexa Imaging by 5.4% in the 1st quarter. Janus Henderson Group PLC now owns 2,100,356 shares of the company’s stock valued at $18,063,000 after buying an additional 107,903 shares during the period. BlackRock Inc. acquired a new position in Lumexa Imaging in the second quarter valued at about $15,771,000. Brigade Capital Management LP acquired a new position in Lumexa Imaging in the second quarter valued at about $7,511,000. Finally, Principal Financial Group Inc. boosted its stake in Lumexa Imaging by 1.2% during the first quarter. Principal Financial Group Inc. now owns 664,136 shares of the company’s stock worth $5,712,000 after buying an additional 7,875 shares during the period.

Lumexa Imaging Stock Up 0.7%

Lumexa Imaging stock opened at $10.89 on Friday. The company has a debt-to-equity ratio of 1.40, a quick ratio of 1.44 and a current ratio of 1.44. The business’s 50-day simple moving average is $11.14 and its two-hundred day simple moving average is $10.33. The company has a market cap of $1.05 billion and a PE ratio of -22.22. Lumexa Imaging has a fifty-two week low of $6.45 and a fifty-two week high of $19.45.

Lumexa Imaging (NASDAQ:LMRI) last announced its quarterly earnings data on Wednesday, August 12th. The company reported $0.20 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.17. The firm had revenue of $264.16 million during the quarter. Lumexa Imaging has set its FY 2026 guidance at 0.710-0.770 EPS. Equities analysts anticipate that Lumexa Imaging will post 0.25 EPS for the current year.

About Lumexa Imaging

Lumexa Imaging is a U.S.-based provider of outpatient diagnostic imaging and radiology services. The company operates imaging centers and offers services designed to support physicians, hospitals, health systems and patients in the diagnosis and monitoring of medical conditions.

Its service portfolio includes advanced imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), mammography, ultrasound and X-ray. Lumexa also provides radiology-related services, including image interpretation and support for referring healthcare providers, through fixed-site and mobile imaging operations.

The company serves communities across the United States through its network of outpatient facilities and healthcare partnerships.